Clinical Trials Logo

Filter by:
NCT ID: NCT05907486 Not yet recruiting - Thrombotic Disorder Clinical Trials

The Use of N-acetylcysteine for Thrombotic Events After Allogenic Hematopoietic Stem Cell Transplantation

Start date: August 1, 2023
Phase: Phase 3
Study type: Interventional

We aim to assess the the efficiency and safety of N-acetylcysteine for prevention of thrombotic events after allogenic hematopoietic stem cell transplantation.

NCT ID: NCT05916443 Not yet recruiting - Colon Cancer Clinical Trials

Dissecting the Biology of Early-onset Colorectal Cancer

Start date: August 1, 2023
Phase:
Study type: Observational

Contrarily to late-onset (LO) colorectal cancer (CRC), early-onset (EO) CRC incidence is increasingly growing. Several factors, such as obesity, chronic inflammation, and intestinal dysbiosis, can increase the general risk of CRC. However, little is known about the biology of EO-CRC. To evaluate whether such selective rise in the incidence of EO-CRC patients mirrors a distinct transcriptomic profile, the investigators will first dissect EO-CRC's transcriptomic landscape. Then, the investigators will investigate the colorectal cancer stem cell (CSC) compartment by in vitro functional assays and RNA-seq analysis. Because our preliminary data indicate an increased aggressiveness of the tumor microenvironment (TME) in EO-CRC,the investigators propose to investigate the CSC niche and the interaction with the TME to dissect the molecular and cellular pathways occurring in EO-CRC. A cohort of 30 EO-CRC patients (<50 years old) will be enrolled and fully characterized. About 10 EO-CRC-derived CSCs in the form of organoids and spheroids will be generated. Since the relevant differences between CR-CSCs isolated from EO-CRC vs LO-CRC patients are still unknown, the investigators will gain information about their specific features such as clonogenic activity, tumorigenic/invasive capacity, and about differences in the mechanisms regulating their cross-talk with TME components.

NCT ID: NCT05917821 Not yet recruiting - Clinical trials for Glioblastoma Multiforme

New Antigens Against Glioblastoma

INAAG
Start date: August 1, 2023
Phase:
Study type: Observational

In this study the investigators will select and develop potential therapeutic monoclonal antibodies (mAbs) for glioblastoma (GB). Activities include tissue microarray (TMA) to test monoclonal antibodies specificity and target distribution, selection of glioblastoma specific functional monoclonal antibodies, identification of candidate targets.

NCT ID: NCT05921331 Not yet recruiting - Breast Cancer Clinical Trials

RJBC-APP and Breast Cancer Treatment Compliance

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

The goal of this multicentric randomized controlled clinical trial is to test the role of mobile medical application (APP) on adjuvant therapy compliance and quality of life (QoL) in patients with early breast cancer. Participants assigned to the Ruijin Breast Cancer APP (RJBC-APP) group can receive treatment reminders, matters needing attention as well as science knowledge and they can communicate with the medical staff during adjuvant treatments while follow-up can only be conducted in outpatient clinic for those in the Control group.

NCT ID: NCT05921734 Not yet recruiting - Atrial Fibrillation Clinical Trials

A Randomized Controlled Study of Ablation Pursuing Atrial Fibrillation Termination as a Procedural Endpoint in Patients With Persistent Atrial Fibrillation

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

This is a prospective, randomized, multi-center trial that aims to investigate whether termination of atrial fibrillation can be used as an ablation endpoint for persistent atrial fibrillation (PersAF). Eligible patients who provided consent were randomly assigned to one of two groups: the AF-termination group (whose ablation endpoint was the pursuit of AF-termination) or the prespecified-ablation group (whose ablation endpoint was prespecified ablation followed by electrical cardioversion).

NCT ID: NCT05922111 Not yet recruiting - Induction of Labor Clinical Trials

Cervical Ripening Balloon for 12 Hours vs. 1 Hour.

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

The aim of this study is a comparison of induction of labor with a cervical ripening balloon left in place for one hour compared to twelve hours. The primary outcome is time to delivery. Women admitted for induction of labor will be recruited and randomized to either a cervical ripening balloon for one hour or twelve hours. the management of delivery after the extraction of the balloon will be left to the discretion of the attending physician.

NCT ID: NCT05922410 Not yet recruiting - Maxillary Sinus Clinical Trials

Different Maxillary Sinus 3D Shapes Assessment Using CBCT Volumetric Segmentation

Start date: August 1, 2023
Phase:
Study type: Observational

the study aims to assist the different 3D shapes of maxillary sinus in adult individuals among Egyptian population,The data collection will be obtained from the data base available at the department of Oral and Maxillofacial Radiology, Faculty of Dentistry, Cairo University. CBCT images will be obtained from Egyptian patients who were referred to the CBCT unit in oral and maxillofacial radiology department for different purposes. The following radiographic examination will be done in Oral and Maxillofacial Radiology Department, Faculty Dentistry, Cairo University. semiautomated segmentation will be performed for the maxillary sinus in both side and then linear and 3D volume will be assessed for each sinus.

NCT ID: NCT05924555 Not yet recruiting - Clinical trials for Long-chain Fatty Acid Oxidation Disorders \(LC-FAOD\)

Exercise Intolerance Study in Long Chain Fatty Acid Oxidation Disorders

EXCITE LcFAOD
Start date: August 1, 2023
Phase:
Study type: Observational

In this study, the exercise tolerance in patients with long-chain fatty acid oxidation disorders (LcFAOD) will be compared to that of healthy volunteers who are carefully matched in terms of age, sex, BMI and physical activity score. The study aims to assess exercise capacity using cardiopulmonary exercise (CPX) tests and activity monitoring over a 7-day period. The hypothesis of the study is that LcFAOD patients will exhibit greater oxygen debt during short periods of exercise compared to healthy individuals. These findings will contribute to a better understanding of exercise intolerance in LcFAOD patients and may guide the development of targeted interventions, such as exercise training programs and enable the analysis of effectiveness of (new) treatments.

NCT ID: NCT05925179 Not yet recruiting - Tooth Diseases Clinical Trials

Effects of Antibiotic Prophylaxis on the Healing Parameters Following Surgical Crown Lengthening

SCLABP
Start date: August 1, 2023
Phase: Phase 4
Study type: Interventional

The goal of this clinical trial is to test the effects of prophylactic antibiotics in healthy individuals who are in need of surgical crown lengthening. The main question it aims to answer is if single dose antibiotics prior to surgical crown lengthening has any effects on the healing outcomes. Participants will be asked to take either - 2 g of amoxicillin + clavulanate, or - placebo, one hour prior to surgery and without knowing what medicine they took. Researchers will compare the wound healing and self-reported outcomes of the antibiotics group and placebo group.

NCT ID: NCT05927870 Not yet recruiting - Clinical trials for Gall Bladder Disease

Ultrasound Guided Percutaneous Cholecystostomy.

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

Surgical cholecystostomy has proven value in the management of both inflammatory and obstructive biliary tract disease